Award
National Cancer Institute PA-23-260
PROX1-dependent epigenetic regulation of phenotypic plasticity during colorectal cancer metastasis
Recipient
WEILL MEDICAL COLL OF CORNELL UNIV
Award Amount
$55,114.00
Ceiling
$55,114.00
Awarded
July 15, 2026
Identifier
PA-23-260
Research project awarded by the National Cancer Institute to Weill Medical College of Cornell University for studying epigenetic regulation in colorectal cancer metastasis, with a project period from July 2025 to July 2029 and an estimated value of $55,114.
Description
This is a research project funded by the NIH/NCI focusing on epigenetic mechanisms in colorectal cancer metastasis. The project involves in vitro and in vivo studies, including organoid models and epigenetic profiling.